| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 17.262 | 57.044 | 49.961 | 26.419 | 29.923 | - |
| Total Income - EUR | - | - | - | - | 17.262 | 58.177 | 49.961 | 57.185 | 30.057 | - |
| Total Expenses - EUR | - | - | - | - | 10.703 | 54.644 | 48.809 | 46.455 | 24.910 | - |
| Gross Profit/Loss - EUR | - | - | - | - | 6.559 | 3.533 | 1.153 | 10.730 | 5.147 | - |
| Net Profit/Loss - EUR | - | - | - | - | 6.386 | 3.001 | 653 | 10.144 | 4.861 | - |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Litherapy Lt International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 14.730 | 10.562 | 0 | 0 | - |
| Current Assets | - | - | - | - | 7.636 | 5.440 | 3.079 | 19.841 | 10.180 | - |
| Inventories | - | - | - | - | 0 | 0 | 0 | 452 | 0 | - |
| Receivables | - | - | - | - | 0 | 5.129 | 3.029 | 17.719 | 3.891 | - |
| Cash | - | - | - | - | 7.636 | 311 | 49 | 1.670 | 6.288 | - |
| Shareholders Funds | - | - | - | - | 6.428 | 7.131 | 7.626 | 14.592 | 9.312 | - |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | - | 1.208 | 13.039 | 6.015 | 5.249 | 868 | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4613 - 4613" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Litherapy Lt International S.r.l.